Exodus Point Capital Management, LP Mirum Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$23.57 - $34.85 $487,239 - $720,419	-20,672 Reduced 32.09%	43,747 $1.5 Million
Q1 2024 May 14, 2024	BUY	$24.92 - $30.02 $1.61 Million - $1.93 Million	64,419 New	64,419 $1.62 Million
Q1 2022 May 13, 2022	SELL	$15.5 - $23.93 $813,347 - $1.26 Million	-52,474 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$13.05 - $19.35 $329,134 - $488,026	25,221 Added 92.54%	52,474 $837,000
Q3 2021 Nov 15, 2021	BUY	$13.95 - $20.18 $380,179 - $549,965	27,253 New	27,253 $543,000
Q2 2021 Aug 16, 2021	SELL	$15.84 - $20.6 $230,788 - $300,142	-14,570 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.29 - $21.92 $237,345 - $319,374	14,570 New	14,570 $289,000
Q3 2020 Nov 16, 2020	SELL	$18.4 - $26.59 $323,840 - $467,984	-17,600 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$11.51 - $20.97 $202,576 - $369,072	17,600 New	17,600 $342,000

190

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.64B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.